HYOSCYAMINE SULFATE
Active substance: hyoscyamine
INJECTION, SOLUTION · HYOSCYAMINE SULFATE .5 mg/mL
United StatesActive
Marketing holder: BPI Labs LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- HYOSCYAMINE SULFATE · .5 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-754b-735a-bfdb-e788425d211e,01a1208c-7f0b-734b-8907-93447749b455,01a1208c-8a8f-7044-9f4d-33663cd5fced,01a1208c-9218-7d56-80aa-c83f8f95495d,01a1208c-92d8-7764-9fea-f271cd2e1a8b;count=55 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 54288-111
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 54288-111 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 54288-111 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 54288-111 · Verified 2026-10-09 · open in source